Form 4: Omada Health Director Acquires Shares

Omada Health Director Julie D. Klapstein acquired 10,882 shares of common stock through restricted stock units.

Summary

• Julie D. Klapstein, a Director at Omada Health, Inc., acquired 10,882 shares of common stock on June 16, 2026.
• The acquisition was made through restricted stock units (RSUs) which entitle the holder to one share of common stock per RSU upon vesting.
• These RSUs are set to fully vest on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of stockholders, provided the reporting person remains in service.
• Following this transaction, Klapstein beneficially owns 21,316 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard vesting and acquisition of shares by a director, rather than a significant new investment or divestment.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 10,882 shares by a Director indicates continued commitment to the company.

Future Outlook

The restricted stock units acquired are scheduled to vest on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, subject to continued service.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of shares by a director, are closely watched by the market as potential indicators of management's confidence in the company's performance and future outlook within the digital health sector.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively, suggesting confidence in the company's value.
• Employees: The vesting schedule of RSUs impacts employee compensation and retention strategies.
• Management: Demonstrates adherence to reporting requirements for beneficial ownership changes.

Next Steps

• Vesting of restricted stock units on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Director, Beneficial Ownership, Common Stock